1. France Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
Visiomed Group S.A.

Visiomed Group S.A.

ALVMG.PA
Visiomed Group S.A.undefined flagEuronext Paris
0.17
EUR
+0.00
- -
52.99MMarket Cap
Visiomed Group S.A.
ALVMG.PA
(Euronext Paris)

Recent

price

0.17

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
FRC
35.98
84.37
143.14
126.23
74.29
69.73
26.79
19.1
8.81
4.94
0.71
0.75
0.05
0.05
0.05
Revenue per Share
-10.03
-16.96
-26.27
-25.79
-17.19
-13.61
-17.91
-26.99
-11.08
-11.18
-1.68
-0.2
-0.03
-0.02
- -
Basic EPS, GAAP
- -
-21.67
-51.85
-17.14
-17.78
-0.44
-22.48
-23.72
-13.84
-7.37
-1.59
-0.44
-0.05
-0.03
-0.01
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
30.16
96.04
56.87
16.79
21.91
17.71
-13.34
0.89
-7.16
-1.01
-0.64
-0.02
-0.01
0.01
Book Value per Share
- -
-17.1
32.54
8.05
1.1
-2.47
17.07
4.6
5.77
-2.57
-0.41
-0.19
-0.06
0.02
- -
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
1
2
14
25
138
264
294
Basic Weighted Avg Shares
4
10
13
14
11
13
11
9
10
9
10
19
7
14
14
Sales/Revenue/Turnover
-22.8
-14.98
-14.36
-17.2
-16.97
-17.39
-73.48
-145.43
-125.22
-211.99
-213.43
-34.79
-51.26
-27.1
6.95
Operating Margin (%)
- -
1
1
1
1
1
- -
1
1
1
4
-2
- -
3
3
Depreciation Expense
-1
-2
-2
-3
-3
-3
-7
-13
-13
-20
-24
-5
-4
-5
1
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-27.87
-20.1
-18.35
-20.43
-23.14
-19.52
-66.86
-141.32
-125.79
-226.45
-234.96
-27.14
-62.14
-36.53
6.58
Profit Margin (%)
- -
-1
4
2
2
4
8
5
6
-3
-3
-4
-3
1
2
Working Capital
- -
2
1
1
2
1
- -
3
- -
- -
- -
- -
5
5
8
LT Debt
- -
4
8
6
5
4
12
8
13
- -
-5
-4
14
24
25
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
-112.46
-38.08
-38.42
-59.72
-77.23
-127.98
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-179.29%
-375.01%
1.97%
Free Cash Flow
1,055.56%
-17.5%
-79.36%
Net Income, GAAP
14.34%
-33.84%
-117.09%
Sales/Revenue/Turnover
11.74%
27.32%
-5.12%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
7
2022
- -
- -
- -
- -
14
2023
- -
- -
- -
- -
14

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
-0.03
2022
- -
- -
- -
- -
-0.02
2023
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
Similar Companies
COLTENE Holding AG (CLTN.SW)
Remedent, Inc. (REMI)
Becton, Dickinson and Company (BDXB)
Tofflon Science and Technology Group Co., Ltd. (300171.SZ)
Merit Medical Systems, Inc. (MMSI)
Hogy Medical Co.,Ltd. (HGYMF)
Business
Klea Holding SA (formerly Visiomed Group SA; Ticker: ALVMG.PA), founded in 2007 and headquartered in Paris, France, is an international holding company focused on acquiring, developing, and digitalizing businesses across multiple sectors, with a core emphasis on innovative healthcare technologies and services; it operates through subsidiaries including Smart Salem, Smart Health, and Bewellthy. The company provides an ecosystem of health solutions via BewellConnect, encompassing enriched and assisted teleconsultation, remote home monitoring, hospital monitoring, tele-expertise, tele-assistance, and tele-regulations; Smart Salem, which runs premium digitalized medical centers in Dubai offering administrative screenings for residency and work visas, preventive health check-ups, and medical fitness tests using advanced automation, robotics, artificial intelligence, and virtual reality to detect nearly 35 diseases in seven minutes; and Bewellthy's connected health offerings, including the VisioCheck telemedicine station (under 300g, available as a case, station, or modular space), software platforms, and health concierge services deployed in France, Italy, the USA, and other international markets. Smart Health delivers innovative diagnostics and preventive care solutions in Saudi Arabia, targeting large-scale medical screening markets. In June 2024, the company rebranded from Visiomed Group SA to Klea Holding SA to reflect its expanded strategy beyond healthcare into multi-sector acquisitions and digitalization; it formed Smart Health in September 2023 as a joint venture (59% owned by Klea Holding) with Abrar Communications Co. and Al-Ghazzawi Group to expand in Saudi Arabia, including plans for a first medical center in Riyadh's King Abdullah Financial District by late 2024; additionally, it reported record 2024 growth of +24% with Q4 acceleration to +33%, strong 2023 financials including +38% normalized revenue growth to €3.5 million EBITDA, and ongoing expansions like new Smart Salem centers in Dubai's DIFC and DKP areas. Klea Holding serves government agencies, healthcare professionals, enterprises, and individual consumers primarily in the Middle East (UAE, Saudi Arabia), Europe (France, Italy), and North America (USA), positioning itself as a debt-free, agile holding with transparent governance under President and CEO Raphael Smila.